Jens Aarøe - Concepedia

Author

Jens Aarøe

Aalborg University Hospital ORCID

Also Known As

Aarøe Jens, Aarøe, J, J Aaroe, J Aarøe, J. AARØE, J. Aarøe, Jens Aaroe, Jens Aarøe, Leif Thuesen, Lisette Jensen

Publications

5.3K

Citations

H-Index

Concepts

All Affiliations

Aalborg University Hospital Aarhus University Hospital Odense University Hospital Rigshospitalet University of Copenhagen

About

Jens Aarøe is an author at Aalborg University Hospital specializing in cardiovascular disease, cardiology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	19	2.6K
2	Public Health	3	3	144
3	Health Sciences	2	2	73
4	Biomedical Engineering	1	1	202
5	Clinical Nutrition	1	1	57

Jens Aarøe

Publications

4.7K

Citations

H-Index

Page 1

	Year	Citations
Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial Thomas Engstrøm, Henning Kelbæk, Steffen Helqvist, The Lancet Percutaneous Coronary InterventionCardiovascular DiseaseComplete RevascularisationCulprit LesionSurgery	2015	947
Randomized Study on Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions Terje K. Steigen, Rune Wiseth, Andrejs Ērglis, Circulation	2006	720
Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial Derek J. Hausenloy, Rajesh Kharbanda, Ulla Møller, The Lancet	2019	309
Randomized Comparison of Final Kissing Balloon Dilatation Versus No Final Kissing Balloon Dilatation in Patients With Coronary Bifurcation Lesions Treated With Main Vessel Stenting Matti Niemelä, Kari Kervinen, Andrejs Ērglis, Circulation	2010	301
Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial Klaus Rasmussen, Anne Kaltoft, Per Thayssen, The Lancet Percutaneous Coronary InterventionSort Out IiiSuperiority TrialSirolimus-eluting Coronary StentsCardiovascular Disease	2010	210
Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial Henning Kelbæk, Dan Eik Høfsten, Lars Køber, The Lancet Percutaneous Coronary InterventionDanami 3-DeferCardiovascular DiseaseSurgeryAcute Myocardial Infarction	2016	203
Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial Evald Høj Christiansen, Lisette Okkels Jensen, Per Thayssen, The Lancet Percutaneous Coronary InterventionSort Out VCardiovascular DiseaseEndovascular TechniqueLumen-apposing Metal Stent	2013	202
Fish Consumption, n-3 Fatty Acids in Cell Membranes, and Heart Rate Variability in Survivors of Myocardial Infarction With Left Ventricular Dysfunction Jeppe Hagstrup Christensen, Eva Korup, Jens Aarøe, The American Journal of Cardiology CardiomyopathyHeart FailureCardiovascular DiseaseOmega-3 Fatty AcidAtherosclerosis	1997	184
Long-Term Results After Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions Niels Ramsing Holm, Andrejs Ērglis, Indulis Kumsārs, Journal of the American College of Cardiology Percutaneous Coronary InterventionEndovascular TechniqueCardiovascular DiseaseCardiologyMedicine	2013	176
Randomized Comparison of Everolimus-Eluting and Sirolimus-Eluting Stents in Patients Treated With Percutaneous Coronary Intervention Lisette Okkels Jensen, Per Thayssen, Henrik Steen Hansen, Circulation	2012	156

Page 1